Open Label Extension Study of 23mg Donepezil Sustained Release in Patients with Moderate to Severe Alzheimer¿s Disease (E2020-G000-328) (2008–2010)

Grant type:
Icon Clinical Research Pty Limited
Researchers:
Funded by:
ICON Clinical Research Pty Limited